16 Jan 2013:
Insecticides Pose Threat
To Bee Populations, Report Says
European scientists have found that imidacloprid, the world’s most widely used insecticide, poses “unacceptable” risks to bee populations
, a finding that some groups hope will result in a ban on the chemical. Asked to assess the health risks of imidacloprid and two other neonicotinoids — clothianidin and thiamethoxam — as seed treatment or as granules, the European Food Safety Authority (EFSA) concluded
that the chemicals should be used only on crops that are “not attractive to honeybees” because of possible risk of exposure through nectar and pollen. Some researchers have said the neonicotinoids make bees more vulnerable to pathogens and could be a factor in so-called “colony collapse disorder
,” a phenomenon that has decimated honeybee populations for several years. A spokesman for Bayer, which manufactures imidacloprid, told the Guardian
that the EFSA report does not alter existing risk assessments and warned against bans based on “an over-interpretation of the precautionary principle.”
Yale Environment 360 is
a publication of the
Yale School of Forestry
& Environmental Studies
Yale Environment 360
articles are now available in Spanish and Portuguese on Universia
, the online educational network. Visit the site.
Business & Innovation
Policy & Politics
Pollution & Health
Science & Technology
Antarctica and the Arctic
Central & South America
Photographer Robert Wintner documents the exquisite beauty and biodiversity of Cuba’s unspoiled coral reefs. View the gallery.
is now available for mobile devices at e360.yale.edu/mobile
The Warriors of Qiugang
, a Yale Environment 360
video, chronicles a Chinese village’s fight against a polluting chemical plant. It was nominated for a 2011 Academy Award for Best Documentary Short.
Watch the video.
Top Image: aerial view of Iceland
. © Google & TerraMetrics.
A three-part series Tainted Harvest
looks at the soil pollution crisis in China, the threat it poses to the food supply, and the complexity of any cleanup. Read the series.